AR and posterior cortical atrophy: Therefore, deciphering phenotypic consequences of clinical AR mutants in response to a variety of endogenous and therapeutic ligands helps to provide useful insights into the improvement of PCa treatments by understanding the genetic predispositions to PCa development and severity between individuals in therapies.